United States · Platforms & data · The Motley Fool

Bristol Myers Squibb: Bargain Buy or Value Trap?

Published by The Motley Fool · United States 1 h ago

The healthcare stock trades at a forward earnings multiple of just nine, and its growth rate has been in the low single digits this year.

Read the full article on The Motley Fool Sign in to save

MarketNews shows the headline and summary published by the outlet. The full article is on the publisher's website. (www.fool.com)

Also worth reading

Is it curtains for COLA? Saving Social Security could mean changing the cost-of-living adjustment.

Cadence unveils suite of AI models that chipmakers can run in-house

Toncoin (TON) Price Prediction 2025, 2026, 2027-2030

Love Musk or Hate Him, Here’s How I’m Building My SpaceX Position

SPCX Stock Slips Premarket: Retail Speculates Elon Musk Could Snap Up Cerebras After Chipmaker’s Slump

Market News